Note 4 - Intangible Assets, Net

12 Months Ended

Jun. 30, 2015

Intangible Assets Disclosure [Text Block]

Note 4. Intangible Assets, net

Intangible assets consist of trade names, license fees from the Branded Proprietary Products Segment, and unpatented technology from the Other Nutraceutical Businesses Segment. The carrying amount of other intangible assets, net is as follows as of:

	June 30, 2015						June 30, 2014
	Gross Carrying		Accumulated				Gross Carrying		Accumulated
	Amount		Amortization		Net		Amount		Amortization		Net

Trade names and patents	$	1,525	$	891	$	634	$	1,525	$	815	$	710
Unpatented technology		547		540		7		547		500		47
License agreement		347		245		102		347		224		123
Total	$	2,419	$	1,676	$	743	$	2,419	$	1,539	$	880

Amortization expense recorded on intangible assets for each of the fiscal years ended June 30, 2015 and 2014 was $137. Amortization expense is recorded on the straight-line method over periods ranging from 13 years to 20 years based on contractual or estimated lives and is included in selling and administrative expenses. Tests for impairment or recoverability are performed at least annually and require significant management judgment and the use of estimates which the Company believes are reasonable and appropriate at the time of the impairment test. Future unanticipated events affecting cash flows and changes in market conditions could affect such estimates and result in the need for an impairment charge. The Company also re-evaluates the periods of amortization to determine whether circumstances warrant revised estimates of current useful lives. No impairment losses were identified or recorded in the fiscal years ended June 30, 2015 and 2014 on the Company’s intangible assets.

The estimated annual amortization expense for intangible assets for the five succeeding fiscal years is as follows:

Year ending	Amortization
June 30,	Expense

2016	$	104
2017		97
2018		97
2019		97
2020		97
Thereafter		251
Total	$	743